The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-opioid Analgesics Market Research Report 2025
Synopsis
The global Non-opioid Analgesics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Non-opioid Analgesics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-opioid Analgesics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-opioid Analgesics include AbbVie Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Centrexion Therapeutics, Cara Therapeutics and Medropharm GmbH., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-opioid Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Analgesics.
Report Scope
The Non-opioid Analgesics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-opioid Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-opioid Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc
Pfizer, Inc
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Centrexion Therapeutics
Cara Therapeutics
Medropharm GmbH.
Segment by Type
NSAIDs
Acetaminophen
Local Anesthetics
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-opioid Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-opioid Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Non-opioid Analgesics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Non-opioid Analgesics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-opioid Analgesics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-opioid Analgesics include AbbVie Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Centrexion Therapeutics, Cara Therapeutics and Medropharm GmbH., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-opioid Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Analgesics.
Report Scope
The Non-opioid Analgesics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-opioid Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-opioid Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc
Pfizer, Inc
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Centrexion Therapeutics
Cara Therapeutics
Medropharm GmbH.
Segment by Type
NSAIDs
Acetaminophen
Local Anesthetics
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-opioid Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-opioid Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Non-opioid Analgesics Market Overview
1.1 Product Overview and Scope of Non-opioid Analgesics
1.2 Non-opioid Analgesics Segment by Type
1.2.1 Global Non-opioid Analgesics Market Value Comparison by Type (2024-2030)
1.2.2 NSAIDs
1.2.3 Acetaminophen
1.2.4 Local Anesthetics
1.3 Non-opioid Analgesics Segment by Application
1.3.1 Global Non-opioid Analgesics Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Non-opioid Analgesics Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Analgesics Revenue 2019-2030
1.4.2 Global Non-opioid Analgesics Sales 2019-2030
1.4.3 Global Non-opioid Analgesics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-opioid Analgesics Market Competition by Manufacturers
2.1 Global Non-opioid Analgesics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-opioid Analgesics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-opioid Analgesics Average Price by Manufacturers (2019-2024)
2.4 Global Non-opioid Analgesics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-opioid Analgesics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-opioid Analgesics, Product Type & Application
2.7 Non-opioid Analgesics Market Competitive Situation and Trends
2.7.1 Non-opioid Analgesics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-opioid Analgesics Players Market Share by Revenue
2.7.3 Global Non-opioid Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-opioid Analgesics Retrospective Market Scenario by Region
3.1 Global Non-opioid Analgesics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-opioid Analgesics Global Non-opioid Analgesics Sales by Region: 2019-2030
3.2.1 Global Non-opioid Analgesics Sales by Region: 2019-2024
3.2.2 Global Non-opioid Analgesics Sales by Region: 2025-2030
3.3 Global Non-opioid Analgesics Global Non-opioid Analgesics Revenue by Region: 2019-2030
3.3.1 Global Non-opioid Analgesics Revenue by Region: 2019-2024
3.3.2 Global Non-opioid Analgesics Revenue by Region: 2025-2030
3.4 North America Non-opioid Analgesics Market Facts & Figures by Country
3.4.1 North America Non-opioid Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-opioid Analgesics Sales by Country (2019-2030)
3.4.3 North America Non-opioid Analgesics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-opioid Analgesics Market Facts & Figures by Country
3.5.1 Europe Non-opioid Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-opioid Analgesics Sales by Country (2019-2030)
3.5.3 Europe Non-opioid Analgesics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-opioid Analgesics Market Facts & Figures by Country
3.6.1 Asia Pacific Non-opioid Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-opioid Analgesics Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-opioid Analgesics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-opioid Analgesics Market Facts & Figures by Country
3.7.1 Latin America Non-opioid Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-opioid Analgesics Sales by Country (2019-2030)
3.7.3 Latin America Non-opioid Analgesics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-opioid Analgesics Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-opioid Analgesics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-opioid Analgesics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-opioid Analgesics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-opioid Analgesics Sales by Type (2019-2030)
4.1.1 Global Non-opioid Analgesics Sales by Type (2019-2024)
4.1.2 Global Non-opioid Analgesics Sales by Type (2025-2030)
4.1.3 Global Non-opioid Analgesics Sales Market Share by Type (2019-2030)
4.2 Global Non-opioid Analgesics Revenue by Type (2019-2030)
4.2.1 Global Non-opioid Analgesics Revenue by Type (2019-2024)
4.2.2 Global Non-opioid Analgesics Revenue by Type (2025-2030)
4.2.3 Global Non-opioid Analgesics Revenue Market Share by Type (2019-2030)
4.3 Global Non-opioid Analgesics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-opioid Analgesics Sales by Application (2019-2030)
5.1.1 Global Non-opioid Analgesics Sales by Application (2019-2024)
5.1.2 Global Non-opioid Analgesics Sales by Application (2025-2030)
5.1.3 Global Non-opioid Analgesics Sales Market Share by Application (2019-2030)
5.2 Global Non-opioid Analgesics Revenue by Application (2019-2030)
5.2.1 Global Non-opioid Analgesics Revenue by Application (2019-2024)
5.2.2 Global Non-opioid Analgesics Revenue by Application (2025-2030)
5.2.3 Global Non-opioid Analgesics Revenue Market Share by Application (2019-2030)
5.3 Global Non-opioid Analgesics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Corporation Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Non-opioid Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Inc Non-opioid Analgesics Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Corporation Information
6.2.2 Pfizer, Inc Description and Business Overview
6.2.3 Pfizer, Inc Non-opioid Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer, Inc Non-opioid Analgesics Product Portfolio
6.2.5 Pfizer, Inc Recent Developments/Updates
6.3 Teva Pharmaceutical Industries Ltd.
6.3.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.3.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product Portfolio
6.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.4 Viatris Inc.
6.4.1 Viatris Inc. Corporation Information
6.4.2 Viatris Inc. Description and Business Overview
6.4.3 Viatris Inc. Non-opioid Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Viatris Inc. Non-opioid Analgesics Product Portfolio
6.4.5 Viatris Inc. Recent Developments/Updates
6.5 Centrexion Therapeutics
6.5.1 Centrexion Therapeutics Corporation Information
6.5.2 Centrexion Therapeutics Description and Business Overview
6.5.3 Centrexion Therapeutics Non-opioid Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Centrexion Therapeutics Non-opioid Analgesics Product Portfolio
6.5.5 Centrexion Therapeutics Recent Developments/Updates
6.6 Cara Therapeutics
6.6.1 Cara Therapeutics Corporation Information
6.6.2 Cara Therapeutics Description and Business Overview
6.6.3 Cara Therapeutics Non-opioid Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cara Therapeutics Non-opioid Analgesics Product Portfolio
6.6.5 Cara Therapeutics Recent Developments/Updates
6.7 Medropharm GmbH.
6.6.1 Medropharm GmbH. Corporation Information
6.6.2 Medropharm GmbH. Description and Business Overview
6.6.3 Medropharm GmbH. Non-opioid Analgesics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medropharm GmbH. Non-opioid Analgesics Product Portfolio
6.7.5 Medropharm GmbH. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-opioid Analgesics Industry Chain Analysis
7.2 Non-opioid Analgesics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-opioid Analgesics Production Mode & Process
7.4 Non-opioid Analgesics Sales and Marketing
7.4.1 Non-opioid Analgesics Sales Channels
7.4.2 Non-opioid Analgesics Distributors
7.5 Non-opioid Analgesics Customers
8 Non-opioid Analgesics Market Dynamics
8.1 Non-opioid Analgesics Industry Trends
8.2 Non-opioid Analgesics Market Drivers
8.3 Non-opioid Analgesics Market Challenges
8.4 Non-opioid Analgesics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Non-opioid Analgesics Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Non-opioid Analgesics Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Non-opioid Analgesics Market Competitive Situation by Manufacturers in 2023
Table 4. Global Non-opioid Analgesics Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Non-opioid Analgesics Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Non-opioid Analgesics Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Non-opioid Analgesics Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Non-opioid Analgesics Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Non-opioid Analgesics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non-opioid Analgesics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-opioid Analgesics, Product Type & Application
Table 12. Global Key Manufacturers of Non-opioid Analgesics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-opioid Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Analgesics as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-opioid Analgesics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Non-opioid Analgesics Sales by Region (2019-2024) & (K Units)
Table 18. Global Non-opioid Analgesics Sales Market Share by Region (2019-2024)
Table 19. Global Non-opioid Analgesics Sales by Region (2025-2030) & (K Units)
Table 20. Global Non-opioid Analgesics Sales Market Share by Region (2025-2030)
Table 21. Global Non-opioid Analgesics Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Non-opioid Analgesics Revenue Market Share by Region (2019-2024)
Table 23. Global Non-opioid Analgesics Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Non-opioid Analgesics Revenue Market Share by Region (2025-2030)
Table 25. North America Non-opioid Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Non-opioid Analgesics Sales by Country (2019-2024) & (K Units)
Table 27. North America Non-opioid Analgesics Sales by Country (2025-2030) & (K Units)
Table 28. North America Non-opioid Analgesics Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Non-opioid Analgesics Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Non-opioid Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Non-opioid Analgesics Sales by Country (2019-2024) & (K Units)
Table 32. Europe Non-opioid Analgesics Sales by Country (2025-2030) & (K Units)
Table 33. Europe Non-opioid Analgesics Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Non-opioid Analgesics Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Non-opioid Analgesics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Non-opioid Analgesics Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Non-opioid Analgesics Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Non-opioid Analgesics Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Non-opioid Analgesics Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Non-opioid Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Non-opioid Analgesics Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Non-opioid Analgesics Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Non-opioid Analgesics Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Non-opioid Analgesics Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Non-opioid Analgesics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Non-opioid Analgesics Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Non-opioid Analgesics Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Non-opioid Analgesics Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Non-opioid Analgesics Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Non-opioid Analgesics Sales (K Units) by Type (2019-2024)
Table 51. Global Non-opioid Analgesics Sales (K Units) by Type (2025-2030)
Table 52. Global Non-opioid Analgesics Sales Market Share by Type (2019-2024)
Table 53. Global Non-opioid Analgesics Sales Market Share by Type (2025-2030)
Table 54. Global Non-opioid Analgesics Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Non-opioid Analgesics Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Non-opioid Analgesics Revenue Market Share by Type (2019-2024)
Table 57. Global Non-opioid Analgesics Revenue Market Share by Type (2025-2030)
Table 58. Global Non-opioid Analgesics Price (US$/Unit) by Type (2019-2024)
Table 59. Global Non-opioid Analgesics Price (US$/Unit) by Type (2025-2030)
Table 60. Global Non-opioid Analgesics Sales (K Units) by Application (2019-2024)
Table 61. Global Non-opioid Analgesics Sales (K Units) by Application (2025-2030)
Table 62. Global Non-opioid Analgesics Sales Market Share by Application (2019-2024)
Table 63. Global Non-opioid Analgesics Sales Market Share by Application (2025-2030)
Table 64. Global Non-opioid Analgesics Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Non-opioid Analgesics Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Non-opioid Analgesics Revenue Market Share by Application (2019-2024)
Table 67. Global Non-opioid Analgesics Revenue Market Share by Application (2025-2030)
Table 68. Global Non-opioid Analgesics Price (US$/Unit) by Application (2019-2024)
Table 69. Global Non-opioid Analgesics Price (US$/Unit) by Application (2025-2030)
Table 70. AbbVie Inc Corporation Information
Table 71. AbbVie Inc Description and Business Overview
Table 72. AbbVie Inc Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Inc Non-opioid Analgesics Product
Table 74. AbbVie Inc Recent Developments/Updates
Table 75. Pfizer, Inc Corporation Information
Table 76. Pfizer, Inc Description and Business Overview
Table 77. Pfizer, Inc Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer, Inc Non-opioid Analgesics Product
Table 79. Pfizer, Inc Recent Developments/Updates
Table 80. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 81. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 82. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product
Table 84. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 85. Viatris Inc. Corporation Information
Table 86. Viatris Inc. Description and Business Overview
Table 87. Viatris Inc. Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Viatris Inc. Non-opioid Analgesics Product
Table 89. Viatris Inc. Recent Developments/Updates
Table 90. Centrexion Therapeutics Corporation Information
Table 91. Centrexion Therapeutics Description and Business Overview
Table 92. Centrexion Therapeutics Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Centrexion Therapeutics Non-opioid Analgesics Product
Table 94. Centrexion Therapeutics Recent Developments/Updates
Table 95. Cara Therapeutics Corporation Information
Table 96. Cara Therapeutics Description and Business Overview
Table 97. Cara Therapeutics Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Cara Therapeutics Non-opioid Analgesics Product
Table 99. Cara Therapeutics Recent Developments/Updates
Table 100. Medropharm GmbH. Corporation Information
Table 101. Medropharm GmbH. Description and Business Overview
Table 102. Medropharm GmbH. Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Medropharm GmbH. Non-opioid Analgesics Product
Table 104. Medropharm GmbH. Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Non-opioid Analgesics Distributors List
Table 108. Non-opioid Analgesics Customers List
Table 109. Non-opioid Analgesics Market Trends
Table 110. Non-opioid Analgesics Market Drivers
Table 111. Non-opioid Analgesics Market Challenges
Table 112. Non-opioid Analgesics Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-opioid Analgesics
Figure 2. Global Non-opioid Analgesics Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Non-opioid Analgesics Market Share by Type in 2023 & 2030
Figure 4. NSAIDs Product Picture
Figure 5. Acetaminophen Product Picture
Figure 6. Local Anesthetics Product Picture
Figure 7. Global Non-opioid Analgesics Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Non-opioid Analgesics Market Share by Application in 2023 & 2030
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Non-opioid Analgesics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Non-opioid Analgesics Market Size (2019-2030) & (US$ Million)
Figure 14. Global Non-opioid Analgesics Sales (2019-2030) & (K Units)
Figure 15. Global Non-opioid Analgesics Average Price (US$/Unit) & (2019-2030)
Figure 16. Non-opioid Analgesics Report Years Considered
Figure 17. Non-opioid Analgesics Sales Share by Manufacturers in 2023
Figure 18. Global Non-opioid Analgesics Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Non-opioid Analgesics Players: Market Share by Revenue in 2023
Figure 20. Non-opioid Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Non-opioid Analgesics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Non-opioid Analgesics Sales Market Share by Country (2019-2030)
Figure 23. North America Non-opioid Analgesics Revenue Market Share by Country (2019-2030)
Figure 24. United States Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Non-opioid Analgesics Sales Market Share by Country (2019-2030)
Figure 27. Europe Non-opioid Analgesics Revenue Market Share by Country (2019-2030)
Figure 28. Germany Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Non-opioid Analgesics Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Non-opioid Analgesics Revenue Market Share by Region (2019-2030)
Figure 35. China Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Non-opioid Analgesics Sales Market Share by Country (2019-2030)
Figure 45. Latin America Non-opioid Analgesics Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Non-opioid Analgesics Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Non-opioid Analgesics Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Non-opioid Analgesics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Non-opioid Analgesics by Type (2019-2030)
Figure 55. Global Revenue Market Share of Non-opioid Analgesics by Type (2019-2030)
Figure 56. Global Non-opioid Analgesics Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Non-opioid Analgesics by Application (2019-2030)
Figure 58. Global Revenue Market Share of Non-opioid Analgesics by Application (2019-2030)
Figure 59. Global Non-opioid Analgesics Price (US$/Unit) by Application (2019-2030)
Figure 60. Non-opioid Analgesics Value Chain
Figure 61. Non-opioid Analgesics Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
